Aperio Group LLC raised its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 3.9% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 10,467 shares of the medical instruments supplier’s stock after buying an additional 391 shares during the period. Aperio Group LLC’s holdings in Merit Medical Systems were worth $399,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. BlackRock Inc. boosted its position in shares of Merit Medical Systems by 7,837.9% in the first quarter. BlackRock Inc. now owns 6,789,527 shares of the medical instruments supplier’s stock worth $196,218,000 after buying an additional 6,703,994 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Merit Medical Systems by 16.1% in the first quarter. Vanguard Group Inc. now owns 4,186,883 shares of the medical instruments supplier’s stock worth $121,001,000 after buying an additional 580,871 shares in the last quarter. Frontier Capital Management Co. LLC boosted its position in shares of Merit Medical Systems by 14.3% in the first quarter. Frontier Capital Management Co. LLC now owns 2,193,723 shares of the medical instruments supplier’s stock worth $63,399,000 after buying an additional 274,150 shares in the last quarter. Ameriprise Financial Inc. boosted its position in shares of Merit Medical Systems by 11.8% in the first quarter. Ameriprise Financial Inc. now owns 1,677,925 shares of the medical instruments supplier’s stock worth $48,491,000 after buying an additional 177,548 shares in the last quarter. Finally, State Street Corp boosted its position in shares of Merit Medical Systems by 1.7% in the first quarter. State Street Corp now owns 1,218,788 shares of the medical instruments supplier’s stock worth $35,223,000 after buying an additional 20,885 shares in the last quarter. Institutional investors own 89.11% of the company’s stock.

Merit Medical Systems, Inc. (MMSI) traded down 0.62% during midday trading on Tuesday, hitting $40.30. 71,489 shares of the stock traded hands. Merit Medical Systems, Inc. has a 12-month low of $20.70 and a 12-month high of $42.60. The stock has a market capitalization of $2.02 billion, a PE ratio of 57.41 and a beta of 1.26. The firm’s 50 day moving average is $39.88 and its 200-day moving average is $34.08.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Wednesday, July 26th. The medical instruments supplier reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.07. The business had revenue of $186.50 million for the quarter, compared to analysts’ expectations of $181.46 million. Merit Medical Systems had a return on equity of 9.78% and a net margin of 4.87%. The firm’s quarterly revenue was up 23.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.26 EPS. On average, analysts anticipate that Merit Medical Systems, Inc. will post $1.26 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Aperio Group LLC Acquires 391 Shares of Merit Medical Systems, Inc. (MMSI)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/08/29/aperio-group-llc-acquires-391-shares-of-merit-medical-systems-inc-mmsi.html.

A number of equities analysts have recently issued reports on MMSI shares. Craig Hallum restated a “buy” rating and issued a $50.00 price objective (up previously from $42.00) on shares of Merit Medical Systems in a research note on Thursday, July 27th. Zacks Investment Research upgraded shares of Merit Medical Systems from a “hold” rating to a “buy” rating and set a $41.00 price objective for the company in a research note on Thursday, June 22nd. SunTrust Banks, Inc. started coverage on shares of Merit Medical Systems in a research note on Tuesday, June 20th. They issued a “buy” rating and a $43.00 price objective for the company. Piper Jaffray Companies restated a “buy” rating and issued a $45.00 price objective on shares of Merit Medical Systems in a research note on Friday, July 28th. Finally, UBS AG cut shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating in a research note on Monday. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company. Merit Medical Systems currently has an average rating of “Buy” and a consensus target price of $40.52.

In other Merit Medical Systems news, Director F. Ann Millner sold 3,106 shares of the firm’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $41.01, for a total value of $127,377.06. Following the sale, the director now owns 6,750 shares of the company’s stock, valued at approximately $276,817.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Kent W. Stanger sold 7,400 shares of the firm’s stock in a transaction dated Tuesday, August 8th. The shares were sold at an average price of $42.22, for a total value of $312,428.00. The disclosure for this sale can be found here. Insiders have sold a total of 98,250 shares of company stock worth $3,932,799 in the last three months. 5.00% of the stock is currently owned by insiders.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Stock Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related stocks with our FREE daily email newsletter.